BHLH148 Antibody

What is BHLH148 and why is it significant in plant research?

BHLH148 is a basic helix-loop-helix transcription factor identified in Arabidopsis thaliana, also known under several aliases including AIF2 (ATBS1 Interacting Factor 2), RITF1 (RSA1 interacting transcription factor 1), F5E6.8, and F5E6_8. Its significance lies in its role within the brassinosteroid (BR) signaling pathway, which is critical for plant growth and development. BHLH148, as part of the atypical bHLH protein subfamily, functions by interacting with other transcription factors to regulate gene expression in response to brassinosteroid hormones .

The protein is particularly important because it represents a class of atypical bHLH proteins that modulate BR signaling by interacting with ATBS1 (Activation-Tagged BRI1 Suppressor 1). This relationship plays a crucial role in suppressing or enhancing BR-related growth phenotypes, making it a valuable target for studying plant hormone signaling mechanisms .

What applications is the BHLH148 antibody suitable for?

The BHLH148 antibody from commercial sources has been validated for several research applications:

• ELISA (Enzyme-Linked Immunosorbent Assay)

• Western Blot (WB), particularly for recombinant immunogen protein/peptide detection

• Immunoassay

• EIA (Enzyme Immunoassay)

The antibody has been specifically tested for reactivity with Arabidopsis thaliana samples, making it appropriate for plant molecular biology and physiology research .

What are the key specifications of commercially available BHLH148 antibodies?

Source: Product specifications from commercial antibody providers

How should BHLH148 antibody validation be performed before experimental use?

Proper antibody validation is essential before conducting experiments with BHLH148 antibody. Follow these methodological steps:

• Genetic control validation: Compare signal between wild-type and gene-disrupted (knockout/knockdown) Arabidopsis plants. This confirms the specificity of the antibody for the target protein.

• Western blot validation: Run samples with and without the primary antibody to confirm specific binding. The expected molecular weight for BHLH148 should be verified against reference data.

• Pre-immune serum controls: If available, compare signals obtained with the antibody versus pre-immune serum to establish baseline non-specific binding.

• Blocking peptide competition: Preincubate the antibody with the immunizing peptide before application to verify epitope-specific binding. Signal should be diminished or eliminated if the antibody is specific.

• Recombinant protein positive control: Use the provided recombinant immunogen (200μg) as a positive control in initial experiments to establish proper detection conditions .

For maximum confidence in antibody specificity, multiple validation methods should be employed rather than relying on a single approach .

What is the optimal protocol for using BHLH148 antibody in Western blot applications?

Optimized Western Blot Protocol for BHLH148 Antibody:

• Sample preparation:

  • Extract plant proteins using a buffer containing 50mM Tris-HCl (pH 7.5), 150mM NaCl, 1% Triton X-100, 0.5% sodium deoxycholate, and protease inhibitor cocktail

  • Quantify protein concentration using Bradford or BCA assay

  • Prepare 20-50μg total protein per lane in sample buffer containing SDS and DTT

• Gel electrophoresis:

  • Use 10-12% SDS-PAGE gel (BHLH148 is approximately in the 25-35kDa range)

  • Run at 100V until samples enter resolving gel, then increase to 150V

• Transfer:

  • Transfer to PVDF membrane (0.45μm) at 100V for 60-90 minutes in cold transfer buffer

  • Confirm transfer with reversible protein stain (Ponceau S)

• Blocking:

  • Block membrane with 5% non-fat dry milk in TBST (TBS + 0.1% Tween-20) for 1 hour at room temperature

• Primary antibody incubation:

  • Dilute BHLH148 antibody 1:1000 in 5% BSA in TBST

  • Incubate overnight at 4°C with gentle rocking

• Washing:

  • Wash 3-5 times with TBST, 5-10 minutes each

• Secondary antibody incubation:

  • Use anti-rabbit IgG-HRP (1:5000) in 5% non-fat dry milk in TBST

  • Incubate for 1 hour at room temperature

• Detection:

  • Wash 3-5 times with TBST

  • Apply ECL substrate and image using a digital imaging system

  • For low abundance targets, consider using enhanced chemiluminescence substrates

• Controls:

  • Include the recombinant immunogen as a positive control

  • Run samples from BHLH148 knockout plants as a negative control

  • Include a loading control (e.g., ACTIN or TUBULIN)

How should the BHLH148 recombinant fusion protein be expressed and purified for antibody validation and as a positive control?

The recombinant BHLH148 protein expression and purification protocol should follow this methodology:

• Construct design:

  • Clone the BHLH148 coding sequence into an expression vector with 6xHis tag (C- or N-terminal)

  • Verify the construct by sequencing

• Expression conditions:

  • Transform into E. coli BL21(DE3) or Rosetta strains

  • Grow cultures at 37°C until OD600 = 0.6-0.8

  • Induce expression with 1mM IPTG

  • Continue expression for 4 hours at 28-30°C (critical for optimal yield)

• Cell lysis:

  • Harvest cells by centrifugation (5000×g, 10 min, 4°C)

  • Resuspend in lysis buffer (50mM NaH₂PO₄, 300mM NaCl, 10mM imidazole, pH 8.0)

  • Add lysozyme (1mg/ml) and incubate on ice for 30 minutes

  • Sonicate to complete lysis (6-10 cycles of 10s on/10s off)

  • Centrifuge (10,000×g, 30 min, 4°C) to remove debris

• Protein purification:

  • Equilibrate Ni-NTA resin with lysis buffer

  • Incubate cleared lysate with resin for 1 hour at 4°C with gentle rotation

  • Wash with increasing concentrations of imidazole (20mM, 50mM)

  • Elute BHLH148-6xHis protein with elution buffer containing 250mM imidazole

  • Collect fractions and analyze by SDS-PAGE

• Quality control:

  • Confirm purity by SDS-PAGE (>90%)

  • Verify identity by Western blot using anti-His antibody

  • Measure protein concentration by Bradford assay or BCA

• Storage:

  • Dialyze against storage buffer (PBS with 10% glycerol)

  • Aliquot to avoid freeze-thaw cycles

  • Store at -80°C for long-term use

This purified recombinant protein serves as an excellent positive control for antibody validation and can help establish detection limits and optimal antibody concentrations.

How can BHLH148 antibody be used to investigate protein-protein interactions in the BR signaling pathway?

BHLH148 antibody can be employed in several advanced techniques to explore protein-protein interactions within the brassinosteroid signaling pathway:

• Co-immunoprecipitation (Co-IP):

  • Use BHLH148 antibody to pull down native protein complexes from plant extracts

  • Identify interacting partners by mass spectrometry or Western blot

  • This approach has successfully identified ATBS1-Interacting Factors (AIFs) and can reveal novel interactions

• Chromatin Immunoprecipitation (ChIP):

  • Use BHLH148 antibody to pull down DNA-protein complexes

  • Identify genomic regions bound by BHLH148 through sequencing (ChIP-seq)

  • Analysis can reveal how BHLH148 cooperates with other transcription factors to regulate BR-responsive genes

• Proximity Ligation Assay (PLA):

  • Combine BHLH148 antibody with antibodies against suspected interacting partners

  • Visualize interactions in situ within intact cells or tissues

  • This provides spatial information about where interactions occur in the cell

• Bimolecular Fluorescence Complementation (BiFC) validation:

  • Use BHLH148 antibody in parallel with BiFC experiments to confirm that fluorescence complementation corresponds to native protein interaction

• Methodological approach for Co-IP:

  • Prepare plant extracts in non-denaturing conditions

  • Pre-clear with protein A/G beads

  • Incubate with BHLH148 antibody (5-10μg per mg of total protein)

  • Capture antibody-protein complexes with fresh protein A/G beads

  • Wash extensively to remove non-specific binding

  • Elute and analyze by mass spectrometry or Western blot with antibodies against suspected interaction partners

Using these approaches, researchers have discovered that BHLH148 (AIF2) interacts with ATBS1 and plays a role in regulating brassinosteroid signaling through protein-protein interactions rather than direct DNA binding .

What techniques can be used to study BHLH148 localization and expression patterns in plant tissues?

Several advanced techniques utilizing the BHLH148 antibody can be employed to determine localization and expression patterns:

• Immunohistochemistry (IHC):

  • Fix plant tissues in paraformaldehyde

  • Embed in paraffin or prepare cryosections

  • Perform antigen retrieval if necessary

  • Block with 5% normal goat serum

  • Incubate with BHLH148 antibody (1:100-1:500 dilution)

  • Detect using fluorescently labeled or HRP-conjugated secondary antibodies

  • Counterstain nuclei with DAPI

  • Image using confocal microscopy

• Immunofluorescence for subcellular localization:

  • Fix plant protoplasts or tissue sections

  • Permeabilize cell membranes with 0.1% Triton X-100

  • Block non-specific binding sites

  • Incubate with BHLH148 antibody

  • Detect with fluorescent secondary antibody

  • Co-stain with markers for cellular compartments (nucleus, ER, Golgi, etc.)

  • Analyze using confocal microscopy

• Immunoelectron microscopy:

  • For ultra-high resolution localization

  • Process tissues for electron microscopy

  • Incubate with BHLH148 antibody

  • Detect with gold-conjugated secondary antibody

  • Examine using transmission electron microscopy

• Tissue-specific expression analysis:

  • Prepare protein extracts from different plant tissues

  • Run parallel Western blots with equal total protein loading

  • Probe with BHLH148 antibody

  • Normalize against housekeeping proteins

  • Quantify relative expression levels across tissues

Previous research has shown that BHLH148 mRNA is expressed at low levels in many aerial tissues that accumulate BRI1 and BIN2 gene transcripts, suggesting a potentially broad but tissue-specific functional role . Protein-level studies using these approaches can provide finer details about BHLH148 distribution and subcellular localization.

How can BHLH148 antibody be used in conjunction with genetic approaches to understand BR signaling?

Integrating BHLH148 antibody use with genetic approaches provides powerful insights into BR signaling mechanisms:

• Protein expression analysis in genetic backgrounds:

  • Analyze BHLH148 protein levels in various BR signaling mutants (bri1, bin2, bes1, etc.)

  • Compare protein expression in wild-type vs. BR biosynthesis/perception mutants

  • Assess how BHLH148 levels change in response to BR treatment

  • This approach can reveal regulatory relationships within the pathway

• Complementation studies validation:

  • Use BHLH148 antibody to confirm protein expression in transgenic plants

  • Verify proper expression of BHLH148 variants in complementation experiments

  • Compare protein levels between endogenous and transgene-expressed BHLH148

• RNAi and CRISPR knockout validation:

  • Confirm reduced or absent BHLH148 protein in gene silencing experiments

  • Research has shown that RNAi-induced silencing of ATBS1 and related genes affects BR signaling

  • BHLH148 antibody provides direct confirmation of knockdown/knockout efficiency

• Hormone response studies:

  • Monitor BHLH148 protein levels before and after BR treatment

  • Compare against other BR-responsive proteins

  • Determine if post-translational modifications occur in response to hormone

• Methodological approach for BR treatment studies:

  • Grow seedlings on medium with/without brassinolide (BL, 0.1-1μM)

  • Harvest tissues at defined time points (30min, 1h, 3h, 6h, 24h)

  • Extract proteins and analyze by Western blot with BHLH148 antibody

  • Monitor both total protein levels and potential mobility shifts indicating post-translational modifications

This combined genetic-biochemical approach has revealed that BHLH148 and related proteins can function redundantly in BR signaling, as overexpression of each ATBS1 homolog suppressed the bri1-301 mutation phenotype .

What are common issues when using BHLH148 antibody in Western blot and how can they be resolved?

Advanced troubleshooting tip: Some plant transcription factors like BHLH148 can be difficult to detect due to low abundance and tissue-specific expression. Consider using nuclear extraction protocols to enrich for transcription factors before Western blot analysis .

How can BHLH148 antibody sensitivity and specificity be optimized for challenging experimental contexts?

To enhance sensitivity and specificity of BHLH148 antibody detection in challenging contexts:

• Signal amplification techniques:

  • Tyramide Signal Amplification (TSA) - Can increase sensitivity 10-100 fold

  • Polymer-based detection systems (EnVision, ImmPRESS)

  • Quantum dot conjugates for higher sensitivity in fluorescence applications

• Sample preparation optimization:

  • Nuclear enrichment: Isolate nuclear fraction to concentrate low-abundance transcription factors

  • Use of phosphatase inhibitors: If BHLH148 is regulated by phosphorylation

  • Crosslinking: Use DSP or formaldehyde to stabilize protein complexes before extraction

• Antibody application optimization:

  • Pre-adsorption: Incubate antibody with non-specific proteins from the species being studied

  • Titration experiments: Test multiple dilutions (1:500, 1:1000, 1:2000, 1:5000) to find optimal signal-to-noise ratio

  • Extended incubation: Overnight at 4°C with gentle agitation

• Reducing non-specific binding:

  • Add 0.1-0.5% non-ionic detergents to reduce hydrophobic interactions

  • Include 100-250mM NaCl to reduce ionic interactions

  • Add 1-5% of normal serum from the secondary antibody host species

• Enhanced detection methods:

  • For Western blot: Use high-sensitivity ECL substrates (SuperSignal West Femto)

  • For immunofluorescence: Use high quantum yield fluorophores and spectral unmixing to reduce autofluorescence

• Methodological enhancement for plant samples:

  • Add 1-2% PVPP to extraction buffers to remove phenolic compounds

  • Include 10mM DTT to maintain reducing conditions

  • Add 1% glycerol to stabilize proteins during extraction

These optimizations are particularly important for BHLH148 detection as research has shown that atypical bHLH proteins like BHLH148 are often expressed at low levels in plant tissues .

What controls are essential for validating BHLH148 antibody specificity in plant research?

To ensure rigorous validation of BHLH148 antibody specificity in plant research, implement these essential controls:

• Genetic controls (Gold standard):

  • Wild-type vs. bhlh148 knockout/knockdown plants

  • BHLH148 overexpression lines as positive controls

  • This approach directly tests antibody specificity against genetically modified reference materials

• Technical controls:

  • Omission of primary antibody - To assess background from secondary antibody

  • Pre-immune serum control - To establish baseline non-specific binding

  • Isotype control - Use irrelevant rabbit IgG at the same concentration

  • Blocking peptide competition - Pre-incubate antibody with immunizing peptide

• Sample processing controls:

  • Denaturing vs. non-denaturing conditions - Test if epitope recognition is conformation-dependent

  • Gradient of antigen amounts - To establish detection limits and linearity of signal

• Recombinant protein controls:

  • Use purified BHLH148-6xHis recombinant protein as positive control

  • Add defined amounts to create a standard curve

  • Include related bHLH family proteins to test cross-reactivity

• Cross-validation approaches:

  • Compare antibody results with tagged protein detection (if available)

  • Correlate protein detection with mRNA expression data

  • Use multiple antibodies targeting different epitopes of BHLH148

• Implementation procedure:

  • Run parallel Western blots with primary antibody, pre-immune serum, and antibody plus blocking peptide

  • Include protein extracts from wild-type, knockout, and overexpression lines

  • Document all validation results according to best practices in antibody reporting

Research has demonstrated that BHLH148 functions redundantly with other family members, which increases the importance of thorough specificity validation to ensure the antibody doesn't cross-react with closely related proteins like other AIF family members .

How should researchers interpret contradictory results between BHLH148 protein levels and gene expression data?

When faced with discrepancies between BHLH148 protein levels (detected by antibody) and gene expression data:

• Consider post-transcriptional regulation:

  • miRNA-mediated regulation: Check if BHLH148 mRNA contains binding sites for known miRNAs

  • mRNA stability: Assess if BR signaling affects BHLH148 mRNA half-life

  • Translation efficiency: Investigate if stress conditions alter translation of BHLH148

• Evaluate post-translational regulation:

  • Protein stability: BHLH148 may be subject to regulated proteolysis

  • Studies of related bHLH proteins have shown that protein stability can be regulated by the BR pathway

  • Use proteasome inhibitors (MG132) to test if BHLH148 is subject to proteasomal degradation

• Technical considerations:

  • Sensitivity differences: qRT-PCR may detect low transcript levels that don't produce detectable protein

  • Temporal dynamics: Protein accumulation may lag behind transcriptional induction

  • Spatial differences: Whole-tissue RNA analysis vs. cell-specific protein detection

• Methodological approach to resolve discrepancies:

  • Time-course analysis: Monitor both mRNA and protein levels at multiple time points after treatment

  • Polysome profiling: Assess if BHLH148 mRNA is actively translated

  • Protein half-life determination: Use cycloheximide chase assays to measure BHLH148 stability

  • Cell-type specific analysis: Use fluorescence-activated cell sorting to isolate specific cell types before analysis

• Data integration strategy:

  • Plot protein vs. mRNA levels to identify correlation patterns

  • Consider mathematical modeling to account for synthesis and degradation rates

  • Integrate with other omics data (proteomics, phosphoproteomics) for comprehensive understanding

Research has shown that bHLH proteins involved in BR signaling are often regulated at multiple levels, making integrated analysis of transcriptomic and proteomic data essential for understanding their function .

What quantitative approaches can be used to analyze BHLH148 protein levels in response to stress or hormone treatments?

For rigorous quantitative analysis of BHLH148 protein dynamics:

• Western blot quantification:

  • Use digital imaging systems with wide dynamic range

  • Include standard curve with recombinant BHLH148 protein

  • Normalize to multiple loading controls (ACTIN, TUBULIN, HISTONE H3)

  • Apply statistical analysis (ANOVA with post-hoc tests) to compare treatments

  • Report fold-changes with appropriate error metrics

• Mass spectrometry-based quantification:

  • Targeted proteomics using Selected Reaction Monitoring (SRM)

  • Identify BHLH148-specific peptides for reliable quantification

  • Use isotope-labeled peptide standards for absolute quantification

  • Multiple Reaction Monitoring (MRM) for higher sensitivity detection

• Image-based quantification for localization studies:

  • Use confocal microscopy with standardized acquisition parameters

  • Measure fluorescence intensity in defined cellular compartments

  • Apply deconvolution algorithms to improve signal resolution

  • Use automated image analysis software for unbiased quantification

• Data analysis workflow:

  • Time-series analysis to capture dynamic responses

  • Dose-response curves to determine sensitivity thresholds

  • Principal Component Analysis to identify patterns across multiple treatments

  • Hierarchical clustering to group treatments with similar effects

• Experimental design considerations:

  • Include biological replicates (n≥3) and technical replicates

  • Randomize sample processing to avoid batch effects

  • Include time-matched controls for each treatment

  • Consider tissue/cell-type specificity in sampling strategy

• Advanced statistical approaches:

  • Use mixed-effects models to account for experimental variability

  • Apply ANCOVA when analyzing covariates (e.g., plant age, size)

  • Calculate confidence intervals for all measurements

  • Perform power analysis to determine appropriate sample sizes

Systems biology approaches have revealed that transcription factors like BHLH148 often show complex expression patterns in response to stimuli, highlighting the importance of sophisticated quantitative analysis methods .

How can researchers use BHLH148 antibody to investigate the molecular mechanisms of cross-talk between BR and other hormone signaling pathways?

To investigate hormone cross-talk mechanisms involving BHLH148:

• Co-treatment experiments:

  • Treat plants with BR alone, second hormone alone, and both hormones

  • Monitor BHLH148 protein levels, phosphorylation state, and localization

  • Compare responses to identify synergistic, antagonistic, or additive effects

  • Time-course studies can reveal sequential activation of pathways

• Protein complex analysis:

  • Use BHLH148 antibody for co-immunoprecipitation under different hormone treatments

  • Identify differential protein interactions using mass spectrometry

  • Verify hormone-specific interactions through reciprocal co-IP

  • Apply proximity-dependent labeling (BioID, APEX) to capture transient interactions

• Chromatin dynamics:

  • Perform ChIP-seq with BHLH148 antibody after hormone treatments

  • Identify hormone-specific changes in genomic binding sites

  • Integrate with transcriptome data to connect binding with gene regulation

  • Analyze nucleosome positioning around BHLH148 binding sites

• Post-translational modifications:

  • Use phospho-specific antibodies or mass spectrometry to map modifications

  • Identify kinases/phosphatases that modify BHLH148 in different hormone contexts

  • Create phosphomimetic/phosphodead BHLH148 variants to test functional consequences

  • Monitor ubiquitination status to assess protein stability regulation

• Genetic approach integration:

  • Cross bhlh148 mutants with mutants in other hormone pathways

  • Analyze phenotypes and molecular signatures of single vs. double mutants

  • Use inducible expression systems to temporally control BHLH148 during hormone treatments

• Data integration framework:

  • Create network models incorporating protein-protein interactions

  • Map transcriptional targets to signaling pathways

  • Use systems biology approaches to identify regulatory hubs

  • Apply mathematical modeling to predict pathway crosstalk mechanisms

Research has shown that BHLH148 and other bHLH proteins function within complex signaling networks. For example, BHLH148 (AIF2) interacts with ATBS1, and this interaction appears to play a role in modulating BR signaling outcomes, suggesting potential integration points with other hormone pathways .

How are new antibody development technologies improving the quality and specificity of tools like BHLH148 antibody?

Recent technological advances are transforming antibody development, with important implications for research tools like BHLH148 antibody:

• Recombinant antibody technologies:

  • Phage display libraries allow screening of billions of antibody variants

  • Yeast display systems enable directed evolution for improved specificity

  • Synthetic antibody libraries can be designed for difficult antigens

  • These approaches reduce batch-to-batch variation and improve reproducibility

• Single B-cell cloning:

  • Direct isolation of B cells producing high-affinity antibodies

  • Next-generation sequencing of antibody repertoires

  • Immortalization of specific B cell clones

  • These methods can yield highly specific monoclonal antibodies with defined sequences

• Computational design approaches:

  • Structure-based antibody design using protein modeling

  • Machine learning algorithms to predict optimal antibody sequences

  • De novo antibody design without immunization

  • Recent advances demonstrate atomically accurate design of antibodies to specific epitopes

• Advanced validation technologies:

  • CRISPR knockout cell lines for definitive specificity testing

  • Proteome-wide peptide arrays to assess cross-reactivity

  • Super-resolution imaging for precise localization validation

  • These approaches provide more rigorous characterization of antibody specificity

• Antibody engineering for enhanced properties:

  • Increase stability for harsh extraction conditions

  • Engineer reduced non-specific binding in plant extracts

  • Add recombinant tags for easy detection and purification

  • Develop renewable recombinant versions of effective polyclonal antibodies

The development of computationally designed antibodies represents a particularly exciting advance that could eventually allow researchers to obtain antibodies with predefined binding properties for any desired epitope on proteins like BHLH148 .

What emerging techniques are complementing antibody-based detection of BHLH148 and other plant transcription factors?

Several cutting-edge technologies are emerging as powerful complements to antibody-based approaches:

• CRISPR-based tagging systems:

  • CRISPR/Cas9-mediated endogenous protein tagging

  • Homology-directed repair to introduce epitope tags or fluorescent proteins

  • Allows visualization and purification of native BHLH148 without antibodies

  • Preserves natural expression patterns and regulatory mechanisms

• Proximity labeling technologies:

  • TurboID and miniTurbo for rapid biotin labeling of proximal proteins

  • APEX2 for spatially and temporally restricted protein labeling

  • These methods can map BHLH148 interactomes without antibody-based pull-downs

  • Especially valuable for capturing transient or weak interactions

• Single-cell and spatial transcriptomics:

  • Correlate BHLH148 protein localization with gene expression patterns

  • Map cell-type specific responses to hormones and stresses

  • Integrate with protein-level data for comprehensive understanding

  • Reveals heterogeneity in responses not detectable in bulk assays

• Live-cell imaging approaches:

  • FRET/FLIM to study protein-protein interactions in living cells

  • Optogenetic tools to control BHLH148 activity with light

  • Fluorescent biosensors to monitor signaling dynamics

  • Nanobody-based detection for improved penetration in plant tissues

• Computational prediction methods:

  • Network-based machine learning to predict transcription factor targets

  • AI-driven prediction of protein-protein interactions

  • Molecular dynamics simulations of transcription factor-DNA binding

  • These computational approaches can generate hypotheses to test with experimental methods including antibody-based techniques

Network-based machine learning has already been applied to predict transcription factor targets in rice, providing a computational framework that could be extended to study BHLH148 and related proteins .

What are the most promising research directions for understanding BHLH148 function in plant development and stress responses?

Based on current knowledge and emerging technologies, several research directions hold particular promise:

• Single-cell resolution studies:

  • Apply BHLH148 antibody in single-cell proteomics approaches

  • Map cell-type specific expression patterns during development

  • Identify pioneer cells where BHLH148 first responds to stress

  • This approach could reveal previously undetected spatial patterns of regulation

• Protein complex dynamics:

  • Characterize the composition of BHLH148-containing protein complexes

  • Map how these complexes change during development and stress

  • Identify post-translational modifications that regulate complex formation

  • This would advance our understanding of how BHLH148 functions in diverse contexts

• Structural biology approaches:

  • Determine the crystal structure of BHLH148 alone and in complexes

  • Use cryo-EM to visualize larger regulatory complexes

  • Apply hydrogen-deuterium exchange mass spectrometry to map interaction surfaces

  • Structural insights would guide rational engineering of BHLH148 activity

• Systems biology integration:

  • Create comprehensive models of BR signaling incorporating BHLH148

  • Use multi-omics approaches to connect genotype to phenotype

  • Apply network analysis to position BHLH148 in broader signaling networks

  • This integrative approach could reveal emergent properties of the system

• Translational applications:

  • Engineer BHLH148 activity to enhance crop stress resilience

  • Develop chemical biology tools to modulate BHLH148 function

  • Apply knowledge to improve plant growth under suboptimal conditions

  • This direction could have significant agricultural impacts

• Evolutionary perspective:

  • Compare BHLH148 function across diverse plant species

  • Trace the evolution of the atypical bHLH protein family

  • Identify conserved and divergent aspects of BHLH148 regulation

  • Understanding evolutionary context could reveal fundamental principles of transcription factor function

Research has established that BHLH148 (AIF2) and related atypical bHLH proteins play important roles in BR signaling, potentially by interacting with and titrating other regulatory factors . Building on this foundation, these research directions could substantially advance our understanding of plant hormone signaling networks and their roles in development and stress responses.